« Previous
Next »
Titles
- Prophylaxis for hereditary angioedema with lanadelumab and C1 Inhibitors: effectiveness and value : final evidence report1
- Saving lives and reducing health care costs: how Clean Air Act rules benefit the nation : a report from Trust for America's Health, EDF Environmental Defense Fund1
- Show me the money: economic evaluations of opioid use disorder interventions1
- Taking the long view: investing in Medicaid home and community-based services is cost-effective1
- Targeted immune modulators for rheumatoid arthritis: effectiveness & value : evidence report1
- Targeted immune modulators for rheumatoid arthritis: effectiveness and value : evidence report1
- Targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: effectiveness and value : condition update : final evidence report1
- The business case for diabetes disease management at two managed care organizations: a case study of HealthPartners and Independent Health Association1
- The business case for pharmaceutical management: a case study of Henry Ford Health System1
- The business case for tobacco cessation programs: a case study of group health cooperative in Seattle1
- The comparative clinical effectiveness and value of simeprevir and sofosbuvir in the treatment of chronic hepatitis C infection: a technology assessment : final report1
- The electronic health record in practice: why, how, and what next? : Site visit report1
- The evidence base for cultural and linguistic competency in health care1
- The vaccine industry: does it need a shot in the arm?1
- Using telephone support to manage chronic disease1
- VA health care facilities: leveraging partnerships to address capital investment needs : testimony before the Subcommittee on Health, Committee on Veterans’ Affairs, House of Representatives1
- Value proposition: the role of cost-effectiveness in coverage decisions1
- Value-based coverage policy in the United States and the United Kingdom: different paths to a common goal1
- What difference does Medicaid make?: assessing cost effectiveness, access, and financial protection under Medicaid for low-income adults1